Vericiguat Modulates Osteoclast Differentiation and Bone Resorption via a Balance between VASP and NF-<i>κ</i>B Pathways.

Mediators Inflamm · 2022 · PMC9225892 · PMID 35757109

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

In addition, the early nucleus translocation of p65 after RANKL stimulation with or without Vericiguat as determined by the immune-fluorescent staining suggested an increasing trend at low concentration and a decreasing trend at high concentration ( Figure 5(e) ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.